| Authors: |
Stuart RM; Gates Foundation, Seattle, Washington, USA robyna.s@gmail.com., Newman LM; Gates Foundation, Seattle, Washington, USA., Manguro G; Gates Foundation, Seattle, Washington, USA., Dziva Chikwari C; Department of Infectious Disease Epidemiology, MRC International Statistics & Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.; Biomedical Research and Training Institute, Harare, Zimbabwe., Marks M; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.; Hospital for Tropical Diseases, University College London Hospital, London, UK.; Division of Infection and Immunity, University College London, London, UK., Peters RPH; Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, Switzerland., Klein D; Gates Foundation, Seattle, Washington, USA., Snyder L; Gates Foundation, Seattle, Washington, USA., Kerr C; Gates Foundation, Seattle, Washington, USA., Rao DW; Gates Foundation, Seattle, Washington, USA. |